CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- 4 Planned sale President & CEO sold 25,000 shares at $22.75 ($568,750)
- 4 Planned sale CFO & Head of Corp. Dev. sold 52,000 shares at an average $21.62 ($1,124,335)
- 4 Open-market buy 10% owner bought 60,000 shares at $15.84 ($950,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 1,125,000 shares at $18.00 ($20,250,000)
- 4 Open-market buy Director bought 1,125,000 shares at $18.00 ($20,250,000)
- 4 Open-market buy Director bought 550,000 shares at $18.00 ($9,900,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 5 · 100 filings